164 results
8-K
EX-4.3
BBLG
Bone Biologics Corp
6 Mar 24
Bone Biologics Announces Pricing of $2.0 Million Public Offering
4:20pm
of shares of capital stock and such exercise price being for the purpose of protecting the economic value of this Warrant immediately prior … for the purpose of such dividend, distribution, redemption, rights or warrants, or if a record is not to be taken, the date as of which the holders of the Common
8-K
EX-10.1
BBLG
Bone Biologics Corp
6 Mar 24
Bone Biologics Announces Pricing of $2.0 Million Public Offering
4:20pm
to employees, officers or directors of the Company pursuant to any stock or option plan duly adopted for such purpose, by a majority of the non-employee … members of the Board of Directors or a majority of the members of a committee of non-employee directors established for such purpose for services rendered
8-K
EX-4.1
BBLG
Bone Biologics Corp
6 Mar 24
Bone Biologics Announces Pricing of $2.0 Million Public Offering
4:20pm
and the value of such shares of capital stock, such number of shares of capital stock and such exercise price being for the purpose of protecting … stating (x) the date on which a record is to be taken for the purpose of such dividend, distribution, redemption, rights or warrants, or if a record
8-K
EX-4.2
BBLG
Bone Biologics Corp
6 Mar 24
Bone Biologics Announces Pricing of $2.0 Million Public Offering
4:20pm
for the purpose of protecting the economic value of this Warrant immediately prior to the consummation of such Fundamental Transaction), and which is reasonably … specified, a notice stating (x) the date on which a record is to be taken for the purpose of such dividend, distribution, redemption, rights
424B4
BBLG
Bone Biologics Corp
4 Mar 24
Prospectus supplement with pricing info
5:21pm
on Form 10-K/A filed with the SEC on November 20, 2023, and any amendment or report filed for the purpose of updating such description.
To obtain copies